Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis | Zendy

Raymond C.S. Seet | Zendy; Yi Zhang | Zendy; S. Arthur Moore | Zendy; Eelco F. M. Wijdicks | Zendy; Alejandro A. Rabinstein | Zendy

Open Access

Subtherapeutic International Normalized Ratio in Warfarin-Treated Patients Increases the Risk for Symptomatic Intracerebral Hemorrhage After Intravenous Thrombolysis

Author(s) -

Raymond C.S. Seet,

Yi Zhang,

S. Arthur Moore,

Eelco F. M. Wijdicks,

Alejandro A. Rabinstein

Publication year - 2011

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.614214

Subject(s) - medicine , warfarin , intracerebral hemorrhage , thrombolysis , stroke (engine) , univariate analysis , anesthesia , surgery , multivariate analysis , atrial fibrillation , glasgow coma scale , myocardial infarction , mechanical engineering , engineering

There is uncertainty whether warfarin-treated patients (despite international normalized ratio < 1.7) have increased risks of symptomatic intracerebral hemorrhage after intravenous thrombolysis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research